×
1 222
Fashion Jobs
ESTÉE LAUDER
Clinique - Consultant - Boots Donegall, Belfast - 15 Hours - Permanent
Permanent · Belfast
ESTÉE LAUDER
Clinique - Consultant - Boots Sedley Place, London - 10 Hours - Permanent
Permanent · London
ESTÉE LAUDER
Clinique - Consultant - John Lewis Stratford, London - 10 Hours - Permanent
Permanent · London
ESTÉE LAUDER
Clinique - Consultant - Boots Durham - 6 Hours - Permanent
Permanent · Durham
ESTÉE LAUDER
Clinique - Consultant - Boots Londonderry - 11 Hours - Permanent
Permanent · Londonderry
ESTÉE LAUDER
Clinique - Consultant - Boots Kensington, London - 22.5 Hours - Permanent
Permanent · London
ESTÉE LAUDER
Clinique - Consultant - Boots Donegall, Belfast - 10 Hours - Permanent
Permanent · Belfast
LAIDBACK LONDON
Digital Marketing Manager
Permanent · HARROW
MARSHALLS
70118-lp Detective
Permanent · Banning
ESTÉE LAUDER
Clinique - Consultant - Boots, Watford - 22.5 Hours - Part Time, Permanent
Permanent · Watford
ESTÉE LAUDER
Tom Ford Beauty - Digital Marketing Executive
Permanent · London
ESTÉE LAUDER
Clinique - Consultant - John Lewis Edinburgh - 6 Hours - Permanent
Permanent · Edinburgh
ESTÉE LAUDER
Clinique - Consultant - Boots st Albans- 22.5 Hours - Permanent
Permanent · St Albans
ESTÉE LAUDER
Clinique - Consultant - John Lewis, Oxford Street London - 15 Hours - Permanent
Permanent · London
ESTÉE LAUDER
Tom Ford - Business Manager - Fenwick - Bracknell - 37.5 Hours - Full-Time, Permanent
Permanent · Bracknell
ESTÉE LAUDER
Clinique - Consultant - John Lewis, High Wycombe - 16 Hours - Part Time, Permanent
Permanent · High Wycombe
ESTÉE LAUDER
Clinique - Consultant - Moores, Coleraine - 12 Hours - Part Time, Permanent
Permanent · Coleraine
ESTÉE LAUDER
Clinique - Consultant - Boots, Barnstaple - 7.5 Hours - Part-Time, Permanent
Permanent · Barnstaple
ESTÉE LAUDER
Clinique - Consultant - Boots, Sedley Place - 37.5 Hours - Full Time, Permanent
Permanent · London
NIKE
HR Operations Consultant, London
Permanent · London
ESTÉE LAUDER
Clinique - Consultant - Boots - Cribbs Causeway, Bristol - 7.5 Hours - Part-Time - Permanent
Permanent · Bristol
ESTÉE LAUDER
Clinique - Consultant - Boots Kingston - 15 Hours - Permanent
Permanent · Kingston upon Thames
Advertisements
By
Reuters API
Published
Mar 12, 2021
Share
Download
Download the article
Print
Click here to print
Text size
aA+ aA-

EssilorLuxottica aims recovery to pre-pandemic levels in 2021

By
Reuters API
Published
Mar 12, 2021

EssilorLuxottica is targeting a recovery in its business this year to levels seen before the COVID-19 crisis after the Oakley and Ray-Ban maker's fourth-quarter revenue showed further signs of improvement, it said on Friday.


Reuters



The eyewear maker said positive momentum was already visible in the Asia-Pacific region and that it expected the roll-out of vaccines to start normalizing the business environment in the second quarter.

Its sales rose 1.7% in the fourth quarter at constant currencies to 4.11 billion euros ($4.92 billion), as a rebound in its prescription glasses business offset weak demand for sunglasses from customers staying at home due to the pandemic.

EssilorLuxottica said it expected that trend to continue this year, along with the rise in e-commerce sales.

Chairman and founder Leonardo Del Vecchio said in a statement that he planned to propose to the new board the confirmation of Francesco Milleri as the chief executive officer and Paul du Saillant as deputy CEO.

Milleri's appointment in December had been expected to be temporary until a shareholder meeting this year.

Adjusted operating profit in the second half of 2020 rose 2.3% at constant currencies to 1.25 billion euros.

EssilorLuxottica, which makes eyewear for luxury brands such as Chanel, Prada and Versace, also proposed a final dividend of 1.08 euros per share after resuming payouts in December.

The company, formed by a merger between French lens manufacturer Essilor and Italian spectacles maker Luxottica, said in November it had clawed back some lost sales in the third quarter following the easing of first-wave lockdowns.
 

© Thomson Reuters 2021 All rights reserved.